Safety and Efficacy of Risuteganib in Intermediate Nonexudative AMD: First Time Results From a Phase 2 Study

  • Peter K. Kaiser, MD FASRS
  • Video
  • Published 2019

Peter K. Kaiser, MD

AMD Non-neovascular Symposium


See more